Comparison

CDK9-IN-2 European Partner

Item no. TMO-T14918-2mg
Manufacturer TargetMol
CASRN 1263369-28-3
Amount 2mg
Category
Type Chemicals
Specific against other
Formula C23H25ClFN5
Smiles N[C@H]1CC[C@@H](CC1)Nc1cc(c(Cl)cn1)-c1cccc(NCc2cccc(F)c2)n1
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias CDK,
Available
Bioactivity
CDK9-IN-2 is a special CDK9 inhibitor extracted from patent WO/2012131594A1 (compound CDKI(8)) and has an IC50 of 5 nM and 7 nM in A2058 skin cell line (72 hours) and H929 multiple myeloma cell line (72 hours), respectively.
Molwt
425, 93
Pathway
Cell Cycle/Checkpoint, Others

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close